https://clinicaltrials.gov/ct2/show/NCT03931915?type=Intr&cond=Endometriosis&lupd_s=04%2F16%2F2019&lupd_d=14
Condition : Endometriosis
Interventions : Drug: TAK-385; Drug: Leuprorelin acetate
Sponsor : ASKA Pharmaceutical Co., Ltd.
Not yet recruiting
Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis
NCT03931915
Tue, 30 Apr 2019 12:00:00 EDT
Last Update Posted: 04/30/19 11:33AM